Kansas City Heart Rhythm Research Foundation
This "How caffeine Induces Atrial Tachyarrhythmias" trial will be a multi-center, randomized, double-blinded trial of intravenous caffeine versus placebo among patients undergoing pulmonary vein isolation procedures for Atrial Fibrillation(AF).
Atrial Fibrillation
Intravenous caffeine
Masked Placebo
NA
The mechanism by which caffeine might change cardiac electrophysiologic properties is largely unknown. Most of the prior studies conducted have evaluated the correlation based on the premise of oral consumption. One caveat among such study designs can be underreporting or overreporting the amount of caffeine ingested. To this date, no clinical trials exist that has studied the in vivo effects of caffeine to assess the atrial refractory period and conduction velocity and its potential to cause atrial or ventricular ectopy or sustained arrythmia induction including Atrial Tachycardia(AT)/Atrial Fibrillation(AF)/Ventricular Tachycardia(VT)/Ventricular Fibrillation(VF). As it is hypothesized that decreasing the atrial refractory period can render atria more prone to fibrillation. The pulmonary veins have proven integral to AF pathophysiology, the relationship between pulmonary vein electrophysiology and lifestyle factors in particular has not previously been assessed. It is also not clear if caffeine increases the risk of AF on those patients with known AF diagnosis. To bridge this gap, a randomized controlled trial is proposed to assess the effects of intravenous caffeine on atrial activity during AF ablation procedures.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 100 participants |
Masking : | DOUBLE |
Primary Purpose : | OTHER |
Official Title : | Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation: The COFFEE-AF Trial |
Actual Study Start Date : | 2024-12 |
Estimated Primary Completion Date : | 2025-06 |
Estimated Study Completion Date : | 2025-09 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 21 Years to 90 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Loma Linda University
Loma Linda, California, United States, 92350
Not yet recruiting
Menorah Medical Center
Overland Park, Kansas, United States, 66209
Not yet recruiting
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States, 66211
Not yet recruiting
Overland Park Regional Medical Center
Overland Park, Kansas, United States, 66215
Not yet recruiting
Centerpoint Medical Center Clinic
Independence, Missouri, United States, 64057
Not yet recruiting
Centerpoint Medical Center
Independence, Missouri, United States, 64057
Not yet recruiting
Research Medical Center Clinic
Kansas City, Missouri, United States, 64032
Not yet recruiting
Research Medical Center
Kansas City, Missouri, United States, 64032
Not yet recruiting
Texas Cardiac Arrythmia Institute
Austin, Texas, United States, 78705